Lunaphore wins 2022 MedTech Breakthrough Award

Lunaphore wins 2022 MedTech Breakthrough Award

Annual awards program recognizes outstanding health and medical technology products and companies

LAUSANNE, Switzerland – May 5, 2022 (2:00 PM CEST)Lunaphore, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, today announced that it has been awarded “Best New Technology Solution for Drug Development” in the sixth annual MedTech Breakthrough Awards program conducted by MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies, and products in the global health and medical technology market.

The award honors Lunaphore’s technological achievements, including its flagship product COMET™, which is enabling research applications and the development of targeted therapies in far-reaching fields including immuno-oncology, immunology, neuroscience, and infectious diseases. Furthermore, Lunaphore’s multiplexed spatial biology tools have additional applications in identifying new biomarkers with potential prognostic value and new biomarkers correlated with response to immunotherapies.

“It is an honor to accept this award from MedTech Breakthrough, which recognizes our technology and our mission to make spatial biology accessible to every lab, with the goal of fueling the next generation of scientific research and drug development,” said Ata Tuna Ciftlik, Ph.D., Chief Executive Officer of Lunaphore. “We have seen tremendous growth over the past year, marked by the commercial launch of our COMET™ platform and installations at leading research institutions.”

The mission of the MedTech Breakthrough Awards is to honor excellence and recognize the innovation, hard work, and success in a range of health and medical technology categories, including Telehealth, Clinical Administration, Patient Engagement, Electronic Health Records (EHR), Virtual Care, Medical Devices, Medical Data and many more. This year’s program attracted more than 3,900 nominations from over 15 different countries throughout the world.

“Extracting molecular and cellular information from tissues is critical to answering some of biology’s most pressing questions and could hold the key to the next generation of innovative medicines. However, current technologies are complex, expensive, manual or semi-manual and are not scalable, thus preventing wide adoption of spatial biology in translational and clinical research,” said James Johnson, managing director, MedTech Breakthrough. “By simplifying the staining and imaging process itself, Lunaphore is facilitating the widespread adoption of their breakthrough technology throughout the world. Through their innovations, Lunaphore has established itself as a driving force in the spatial biology revolution for years to come. Congratulations on being our choice for ‘Best New Technology Solution for Drug Development.’”


To learn more about the COMET™ PA platform, please visit:

To learn more about Lunaphore, please visit:



About Lunaphore

Lunaphore Technologies S.A. is a Swiss company born in 2014 with the vision of enabling spatial biology in every laboratory. Lunaphore has developed a game-changing chip technology which can extract spatial proteomic and genomic data from tumors and transform any simple assay into multiplex spatial biology without complexity. Lunaphore empowers researchers to push the boundaries of research to ultimately develop the next generation personalized therapies. For further information on Lunaphore and its products, please visit



About MedTech Breakthrough

Part of Tech Breakthrough, a leading market intelligence and recognition platform for global technology innovation and leadership, the MedTech Breakthrough Awards program is devoted to honoring excellence in medical and health related technology companies, products, services and people. The MedTech Breakthrough Awards provide a platform for public recognition around the achievements of breakthrough health and medical companies and products in categories that include Patient Engagement, mHealth, Health & Fitness, Clinical Administration, Healthcare IoT, Medical Data, Healthcare Cybersecurity and more. For more information visit



For further information contact:


Irene Tamayo

Lunaphore Corporate Communications

Email: [email protected]